S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
OTCMKTS:CLXPF

Cybin (CLXPF) Stock Price, News & Analysis

$3.02
-0.04 (-1.31%)
(As of 08/4/2021)
Today's Range
$2.87
$3.20
50-Day Range
$0.32
$0.46
52-Week Range
$0.49
$3.38
Volume
864,300 shs
Average Volume
551,962 shs
Market Capitalization
$448.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CLXPF stock logo

About Cybin Stock (OTCMKTS:CLXPF)

Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

CLXPF Stock Price History

CLXPF Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
See More Headlines
Receive CLXPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cybin and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLXPF
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$680,000.00
Book Value
$0.44 per share

Miscellaneous

Free Float
N/A
Market Cap
$448.77 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Eric So L.L.B. (Age 45)
    LLB, Co-Founder, Pres & Exec. Chairman
  • Mr. Douglas L. Drysdale (Age 51)
    Chief Exec. Officer
  • Mr. Paul Glavine (Age 31)
    Co-Founder, Chief Growth Officer & Director
  • Mr. John Kanakis (Age 40)
    Co-Founder & Chief Bus. Officer
  • Mr. Greg Cavers (Age 50)
    Chief Financial Officer
  • Dr. Alex L. Nivorozhkin Ph.D. (Age 61)
    Chief Scientific Officer
  • Mr. Gabriel Fahel (Age 45)
    Chief Legal Officer
  • Sara Brittany Somerset
    Chief Communications Officers
  • Lori Challenger
    Chief of Staff
  • James Andrews
    Chief Cultivation & Extraction Officer

CLXPF Stock Analysis - Frequently Asked Questions

How have CLXPF shares performed in 2024?

Cybin's stock was trading at $0.41 at the beginning of the year. Since then, CLXPF stock has increased by 636.6% and is now trading at $3.02.
View the best growth stocks for 2024 here
.

How do I buy shares of Cybin?

Shares of CLXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLXPF) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners